Moreover, increased doxorubicin resistance has been linked with higher METTL1 levels in osteosarcoma, coupled with up-regulated migration, invasion and proliferation mediated by increased translation of the extracellular matrix organizer LOXL2 (78). This evidence concerns the gene METTL1 and osteosarcoma.